Legal & General Group PLC Pro Qr Therapeutics N.V. Transaction History

Legal & General Group PLC

  • $470 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 13, 2020
SELL
$5.84 - $10.51 $326,555 - $587,687
-55,917 Closed
0 $0
Q3 2019

Nov 13, 2019
SELL
$5.76 - $9.44 $63,504 - $104,076
-11,025 Reduced 16.47%
55,917 $323,000
Q4 2018

Feb 15, 2019
BUY
$15.25 - $22.4 $1.02 Million - $1.5 Million
66,942 New
66,942 $1.06 Million

Others Institutions Holding PRQR

# of Institutions
52
Shares Held
17.4M
Call Options Held
37.7K
Put Options Held
21.3K
View Full List

About ProQR Therapeutics N.V.

PRQR Quotes by TradingView
  • Ticker PRQR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,362,096
  • Market Cap $234M
  • Description
  • ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...
More about PRQR
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email